Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2015

Mar 25, 2015

30339_dirs_2015-03-25_d2e24100-5e4f-41db-9f26-d5080c89c6aa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-02-17

Reporting Person: Bedwell Warwick (President, Pharma Pkgs Systems)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-02-17 Common Stock A 5204.0000 $51.5300 Acquired 29362.3800 Direct

Footnotes

F1: Shares represent the portion of the Performance Vesting Restricted Share Awards granted in 2012 that have vested for performance period 11. Amended Form 4 is to account for taxes withheld from original share acquisition number which was not provided when original Form 4 was filed. Original number of 12,263 shares now reflect the tax withholding of 7,059 shares for a total acquisition of 5,204.

F2: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.